Sign In
Buy SWAV
$334.75
+0 (+0%)
At Close: Aug 29, 2024
Shockwave Medical (SWAV) Reports Q4 Loss, Tops Revenue Estimates
06:11pm, Wednesday, 17'th Feb 2021
Shockwave Medical (SWAV) delivered earnings and revenue surprises of -12.20% and 11.60%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
Shockwave Medical Reports Fourth Quarter and Full Year 2020 Financial Results
04:05pm, Wednesday, 17'th Feb 2021
SANTA CLARA, Calif., Feb. 17, 2021 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (Nasdaq: SWAV), a pioneer in the development and commercialization of Intravascular Lithotripsy (IVL) to treat complex ca
Shockwave Medical to Report Fourth Quarter and Full Year 2020 Financial Results on February 17, 2021
04:05pm, Tuesday, 19'th Jan 2021
SANTA CLARA, Calif., Jan. 19, 2021 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (Nasdaq: SWAV), a pioneer in the development and commercialization of Intravascular Lithotripsy (IVL) to treat complex ca
Why ShockWave Medical Stock Jumped Today
04:45pm, Wednesday, 13'th Jan 2021
No news is good news for this company.
Why ShockWave Medical Stock Jumped Today
04:24pm, Tuesday, 05'th Jan 2021
No news was good news for the medical device maker.
7 Under-the-Radar Breakout Stocks for 2021
01:52pm, Tuesday, 15'th Dec 2020
With so much hype baked into the market, smart speculators may want to consider these under-the-radar breakout stocks for 2021. The post 7 Under-the-Radar Breakout Stocks for 2021 appeared first on In
Four New C-Codes for IVL Performed Below the Knee in Hospital Outpatient Setting Four New C-Codes for IVL Performed Below the Knee in Hospital Outpatient Setting
BofA Positive On Medtech Stock ShockWave In The Long Run
03:52pm, Tuesday, 01'st Dec 2020
Smid-cap MedTech company ShockWave Medical Inc (NASDAQ: SWAV) has seen its shares appreciate over 120% year-to-date. The ShockWave Analyst: BofA Securities analyst Bob Hopkins downgraded ShockWave f
Shockwave Medical to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference
08:00am, Wednesday, 18'th Nov 2020
SANTA CLARA, Calif., Nov. 18, 2020 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat complex calcified cardiovascular
ShockWave Is Sending Waves Throughout The Cardiology Community
06:27pm, Sunday, 15'th Nov 2020
ShockWave has key differentiators that look set to make a remedial breakthrough in peripheral vascular interventions. The CAD III and PAD III IVL studies have shown superior efficacy and safety result
Shockwave Medical, Inc. (SWAV) CEO Douglas Godshall on Q3 2020 Results - Earnings Call Transcript
10:49pm, Monday, 09'th Nov 2020
Shockwave Medical, Inc. (SWAV) CEO Douglas Godshall on Q3 2020 Results - Earnings Call Transcript
Recap: ShockWave Medical Q3 Earnings
05:17pm, Monday, 09'th Nov 2020
Shares of ShockWave Medical (NASDAQ:SWAV) were flat in after-market trading after the company reported Q3 results. Quarterly Results Earnings per share were up 17.39% year over year to ($0.38), which
Shockwave Medical Reports Third Quarter 2020 Financial Results
04:05pm, Monday, 09'th Nov 2020
SANTA CLARA, Calif., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (Nasdaq: SWAV), a pioneer in the development and commercialization of Intravascular Lithotripsy (IVL) to treat complex ca
Shockwave IVL Is Superior to Angioplasty in Severely Calcified Peripheral Artery Disease
10:05am, Saturday, 07'th Nov 2020
Disrupt PAD III is Largest Randomized Study of Complex Patients Typically Excluded from Clinical Trials Disrupt PAD III is Largest Randomized Study of Complex Patients Typically Excluded from Clinical
